TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Private Institute Commits $1 Million Pick Up some NIH Grants Left Unfunded April 19, 1985
TCL Archive NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups. January 12, 2007
TCL Archive Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease November 30, 2012
